Asia Pacific Digital Therapeutics Market

The Asia Pacific digital therapeutics market is expected to reach US$ 3,470.31 million by 2028 from US$ 767.23 million in 2021; it is estimated to grow at a CAGR of 24.1% from 2021 to 2028.

The growth of the market is attributed to the rising population with undiagnosed chronic conditions, such as CVDs and diabetes, and increasing number of start-ups in digital therapeutics. However, cyber threat and risk related to data security restrict the market growth.

Digital therapeutics help monitor and manage various chronic disorders, such as diabetes, heart disease, and respiratory infections. There have been various government initiatives that have supported the growth of the digital therapeutics market. In 2021, the Indian government initiated the National Digital Health Mission (NDHM) to increase the preference and adoption of e-healthcare models. It improved the healthcare sectors’ performance by inviting a large number of private players to enter into it. For example, Tattvan is India’s first-of-its-kind telemedicine company having a widespread telemedicine business with its “brick & mortar” model that provides medical diagnosis, prompt cure, guidance, and best consultancy to the patients of the tier-2, tier 3 cities, and tier-4 towns.

Government-aided reimbursements, and increasing number of patients being monitored are expected to encourage startups to enter the digital therapeutics industry. A large percentage of the population in the region is unaware of their diabetic status due to the occurrence of fewer symptoms. Similarly, as per data published in the 10th edition of the IDF Diabetes Atlas, ~239.7 million diabetic people from the age group 20–79 are estimated to be unaware of their disease. It is essential to diagnose diabetes early as it can lead to ailments, such as vision loss, kidney failure, and death in severe conditions. Additionally, people having undiagnosed diabetes opt for healthcare services more frequently than people without diabetes; thus, their healthcare spending is greater than healthy people. The rise in undiagnosed diabetes cases is attributed to inadequate screening facilities in low and high-income countries. With almost half of the global population unaware of diabetes, there is an urgent need to screen, diagnose, and provide appropriate care to people affected by diabetes. Digital therapeutics help detect the signs and symptoms of diabetes early by letting individuals monitor their health by themselves. Thus, the rise in this undiagnosed diabetic population is likely to boost the digital therapeutics market growth in the coming years.

Asia Pacific Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report Request Free Sample PDF

Asia Pacific Digital Therapeutics Strategic Insights

Strategic insights for the Asia Pacific Digital Therapeutics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Digital Therapeutics Report Scope

Asia Pacific Digital Therapeutics Regional Insights

The geographic scope of the Asia Pacific Digital Therapeutics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Asia Pacific Digital Therapeutics Market Segmentation

By Application

• Diabetes
• Cardiovascular Diseases
• Central Nervous System (CNS) Disease
• Respiratory
• Smoking Cessation
• Musculoskeletal Diseases
• Others

By End User

• Patients
• Providers
• Payers
• Employers

By Country

• Australia
• China
• India
• Japan
• South Korea
• Rest of APAC

Company Profiles

• Propeller Health (ResMed)
• Noom, Inc
• Welldoc, Inc.
• Teladoc Health, Inc.
• Fitbit, Inc.